Brownlie Keith L 4
4 · Celldex Therapeutics, Inc. · Filed Jun 21, 2021
Insider Transaction Report
Form 4
Brownlie Keith L
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2021-06-17+12,000→ 12,000 totalExercise: $28.00From: 2022-06-17Exp: 2031-06-17→ Common Stock (12,000 underlying)
Footnotes (1)
- [F1]Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.